Adynxx Inc (ADYX)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
David Ian Johnson
Employees:
81
100 PINE ST., STE. 500, SAN FRANCISCO, CA, 94111
(415) 512-7740

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Adynxx, Inc. focuses on the development and marketing of transcription factor decoy technologies for the treatment of pain and inflammatory diseases. The company was founded in 2007 and is headquartered in San Francisco, California.

Data derived from most recent annual or quarterly report
Market Cap 2.614 Million Shares Outstanding5.808 Million Avg 30-day Volume 3.261 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS
Price to Revenue0.0 Debt to Equity-0.1776 EBITDA0
Price to Book Value0.0 Operating Margin0.0 Enterprise Value24.481 Million
Current Ratio0.166 EPS Growth0 Quick Ratio0.002
1 Yr BETA -2.7168 52-week High/Low 0.0 / Profit Margin0.0
Operating Cash Flow Growth0.0 Altman Z-Score0.0 Free Cash Flow to Firm 1.648 Million
View SEC Filings from ADYX instead.

View recent insider trading info

Funds Holding ADYX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ADYX

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Events (8k)

  • 8-K: filed on 2019-12-17:
    Item 3.02: Unregistered Sales of Equity Securities
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-11-14:
    Item 2.02: Results of Operations and Financial Condition
    Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-10-02:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-08-14:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-07-22:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2019-06-26:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-06-17:
    Item 1.02: Termination of a Material Definitive Agreement
  • 8-K: filed on 2019-06-12:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • 8-K/A: filed on 2019-06-10:
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2019-05-31:
    Item 4.01: Changes in Registrant's Certifying Accountant
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    FLESHER GREGORY J.

    • Director
    0 2019-07-22 0

    GONZALEZ DINA CONTROLLER

    • Officer
    0 2019-05-29 0

    TPG GROUP HOLDINGS (SBS) ADVISORS, INC.

    BONDERMAN DAVID

    COULTER JAMES G

    • 10% Owner
    1,112,290 2019-05-03 0

    DP VIII ASSOCIATES, L.P.

    BLAIR JAMES C

    TREU JESSE I

    DOVEY BRIAN H

    VITULLO NICOLE

    HALAK BRIAN K

    • 10% Owner
    22,527 2019-05-03 0

    DOMAIN PARTNERS VIII, L.P.

    BLAIR JAMES C

    TREU JESSE I

    DOVEY BRIAN H

    VITULLO NICOLE

    HALAK BRIAN K

    • 10% Owner
    3,036,044 2019-05-03 0

    WEBER ECKARD

    • Director
    0 2019-05-03 0

    ABEL STAN E

    • Director
    0 2019-05-03 0

    PODLESAK DENNIS

    • Director
    0 2019-05-03 0

    LEGAULT PIERRE

    • Director
    0 2019-05-03 0

    ORR RICK CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    0 2019-05-03 0

    MAMET JULIEN CHIEF SCIENTIFIC OFFICER

    • Officer
    • Director
    0 2019-05-03 0

    RUTH MATTHEW

    • Director
    0 2019-05-03 0

    MANNING DONALD C. CHIEF MEDICAL OFFICER

    • Officer
    0 2019-05-03 0

    WARUSZ JOSEPH MICHAEL CHIEF FINANCIAL OFFICER

    • Officer
    0 2018-04-01 0

    POSNER BRIAN M CHIEF FINANCIAL OFFICER

    • Officer
    476,421 2017-09-21 0

    BARTON BRADFORD CHIEF OPERATING OFFICER

    • Officer
    558,822 2017-09-21 0

    PIONATI PELLEGRINO SEE REMARKS

    • Officer
    506,601 2017-09-21 0

    WAGNER MARK T

    • Director
    0 2017-06-30 0

    LEONE JOSEPH M

    • Director
    0 2017-06-30 0

    RESTANI GARY C

    • Director
    0 2017-06-30 0

    ZELDIS JEROME B

    • Director
    0 2017-06-30 0

    SKLAR JEFFREY

    • Director
    0 2017-06-30 0

    JOHNSON DAVID IAN PRESIDENT AND CEO

    • Officer
    • Director
    1,994,535 2017-06-28 0

    CELGENE CORP /DE/

    • 10% Owner
    7,342,377 2017-04-11 0

    KUNG WINSTON

    • Director
    0 2016-02-15 0

    AFRICK ANDREW

    • Director
    0 2015-05-06 0

    STEFANSKY DAVID

    • Director
    0 2014-03-18 0

    PEARSEN KENNETH D.

    • Director
    0 2014-03-06 0

    ROSENBLUM RICHARD

    • FORMER DIRECTOR
    No longer subject to file 2014-01-17 0

    SAPIRSTEIN JAMES CEO, THERAPEUTICS DIVISION

    • Officer
    31,662 2014-01-09 0

    KARSEN PERRY A

    • Director
    0 2013-11-27 0

    HARBORVIEW ADVISORS, LLC

    HARBORVIEW VALUE MASTER FUND, L.P.

    HARBORVIEW CAPITAL MANAGEMENT, LLC

    ROSENBLUM RICHARD

    STEFANSKY DAVID

    • Director
    • 10% Owner
    44,021,018 2013-11-11 0

    BERGER STEVEN C CFO, TREASURER AND SECRETARY

    • Officer
    No longer subject to file 2013-09-03 0

    LONDONER KENNETH L

    • Director
    1,859,500 2013-05-20 0

    HARBORVIEW ADVISORS, LLC -

    HARBORVIEW MASTER FUND LP

    HARBORVIEW VALUE MASTER FUND, L.P.

    HARBORVIEW CAPITAL MANAGEMENT, LLC

    ROSENBLUM RICHARD

    STEFANSKY DAVID

    • Officer
    • Director
    • 10% Owner
    • -----
    29,379,728 2012-11-08 0

    KALEN CAPITAL CORP

    • 10% Owner
    0 2012-03-28 0

    HARBORVIEW ADVISORS, LLC -

    HARBORVIEW MASTER FUND LP

    HARBORVIEW VALUE MASTER FUND, L.P.

    ROSENBLUM RICHARD -

    STEFANSKY DAVID -

    • Officer
    • Director
    • 10% Owner
    36,744,498 2011-09-28 0

    HARBORVIEW ADVISORS, LLC MANAGING MEMBER

    HARBORVIEW VALUE MASTER FUND, L.P.

    ROSENBLUM RICHARD PRESIDENT

    STEFANSKY DAVID CHAIRMAN

    • Officer
    • Director
    • 10% Owner
    • MANAGING MEMBER
    0 2011-03-01 0

    GOLDBERG MICHAEL M

    • Director
    0 2011-01-03 0

    STEIN NACHUM

    • Director
    5,400,000 2011-01-03 0

    SIERCHIO JOSEPH

    • Director
    0 2010-12-31 0

    HARBORVIEW MASTER FUND LP

    • 10% Owner
    27,981,999 2010-05-11 0

    HARBORVIEW ADVISORS, LLC

    HARBORVIEW MASTER FUND LP

    HARBORVIEW VALUE MASTER FUND, L.P.

    • 10% Owner
    35,794,498 2010-05-11 0

    BHOGAL JATINDER S

    • Director
    0 2008-09-12 0

    RAYAT HARMEL S SECRETARY/TREASURER

    • Officer
    • Director
    63,253,742 2008-09-08 0

    SCHOMER ROLAND

    • Director
    0 2008-06-18 0

    JIMENEZ JAVIER

    • Director
    0 2008-06-11 0

    MENZLER FRANK PRESIDENT/CEO

    • Officer
    • Director
    0 2008-06-11 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    ADYNXX INC ADYX 2021-12-24 22:15:03 UTC -0.22 0.3 15000
    ADYNXX INC ADYX 2021-12-24 21:45:03 UTC -0.22 0.3 15000
    ADYNXX INC ADYX 2021-12-24 21:15:03 UTC -0.22 0.3 15000
    ADYNXX INC ADYX 2021-12-24 20:45:03 UTC -0.22 0.3 15000
    ADYNXX INC ADYX 2021-12-24 20:15:03 UTC -0.22 0.3 15000
    ADYNXX INC ADYX 2021-12-24 19:45:04 UTC -0.22 0.3 15000
    ADYNXX INC ADYX 2021-12-24 19:15:03 UTC -0.22 0.3 15000
    ADYNXX INC ADYX 2021-12-24 18:45:03 UTC -0.22 0.3 15000
    ADYNXX INC ADYX 2021-12-24 18:15:02 UTC -0.22 0.3 15000
    ADYNXX INC ADYX 2021-12-24 17:45:03 UTC -0.22 0.3 15000
    ADYNXX INC ADYX 2021-12-24 17:15:04 UTC -0.22 0.3 15000
    ADYNXX INC ADYX 2021-12-24 16:45:03 UTC -0.23 0.3 15000
    ADYNXX INC ADYX 2021-12-24 16:15:04 UTC -0.23 0.3 15000
    ADYNXX INC ADYX 2021-12-24 15:45:03 UTC -0.23 0.3 15000
    ADYNXX INC ADYX 2021-12-24 15:15:03 UTC -0.23 0.3 15000
    ADYNXX INC ADYX 2021-12-24 14:45:03 UTC -0.23 0.3 15000
    ADYNXX INC ADYX 2021-12-24 14:15:03 UTC -0.23 0.3 15000
    ADYNXX INC ADYX 2021-12-24 13:45:03 UTC -0.23 0.3 15000
    ADYNXX INC ADYX 2021-12-24 13:15:03 UTC -0.23 0.3 15000
    ADYNXX INC ADYX 2021-12-24 12:45:03 UTC -0.23 0.3 15000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments